Seed funding recipients: Round 2
The Baker Department of Cardiometabolic Health is pleased to announce a second round of seed funding to the value of $500,000. The competitive scheme received projects from several research groups involving staff from the Baker Institute and other Departments throughout the University, collaborating in the Baker Department of Cardiometabolic Health.
The successful projects span new technologies and chronic diseases:
- Acceptability and feasibility of risk guidance in acute myocardial infarction via a technology enabled disease management program led by Associate Professor Melinda Carrington in collaboration with Associate Professor Jo-Anne Manski-Nankervis, Professor Brian Oldenburg, Dr Dominika Kwasnicka and Dr Quan Huynh. Awarded $200,000.
- PRogrEssion of Diabetic Complications (PREDICT) study led by Professor Jonathan Shaw in collaboration with Dr Mervyn Kyi, Associate Professor Shane Hamblin, Associate Professor Agus Salim and Dr Julian Scare. Awarded $100,000.
- Persistent Cardiovascular Effects of COVID-19 led by Dr Erin Howden in collaboration with Associate Professor Luke Burchill, Professor Graeme Maguire, Associate Professor Chiew Wong, Professor Jo Douglass, Dr Quan Huynh, Dr Leah Wright, A/Prof Andre La Gerche & Professor Tom Marwick. Awarded $100,000.
- Development of biodegradable and anti-thrombotic stents led by Professor Amanda Ellis in collaboration with Dr Daniel Heath, Dr Simone Hendriske, Dr Xiaowei Wang, Professor Geoffrey Pietersz, Dr James McFadyen, Dr Laura Bienvenu, Dr Smriti Krishna and Dr Jathushan Palasubramaniam. Awarded $100,000.
These projects will further strengthen the University’s partnership with the Baker Institute and will enable research groups to refine their program of work before progressing to external grant funding opportunities in the future.